Filtros : "Indexado no Medline" "SANTOS, JOSE EDUARDO TANUS DOS" Removido: "Rodrigues, Alfredo José" Limpar

Filtros



Refine with date range


  • Source: Arquivos Brasileiros de Cardiologia. Unidade: FMRP

    Subjects: FARMACOGENÉTICA, FÁRMACOS, SISTEMA CARDIOVASCULAR

    Versão PublicadaAcesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Pâmela Souza et al. Implicações farmacogenéticas de polimorfismos da eNOS para drogas de ação cardiovascular. Arquivos Brasileiros de Cardiologia, v. 96, n. 2, p. e27-e34, 2011Tradução . . Disponível em: https://doi.org/10.1590/s0066-782x2011000200017. Acesso em: 09 jun. 2024.
    • APA

      Silva, P. S., Lacchini, R., Gomes, V. de A., & Tanus-Santos, J. E. (2011). Implicações farmacogenéticas de polimorfismos da eNOS para drogas de ação cardiovascular. Arquivos Brasileiros de Cardiologia, 96( 2), e27-e34. doi:10.1590/s0066-782x2011000200017
    • NLM

      Silva PS, Lacchini R, Gomes V de A, Tanus-Santos JE. Implicações farmacogenéticas de polimorfismos da eNOS para drogas de ação cardiovascular [Internet]. Arquivos Brasileiros de Cardiologia. 2011 ; 96( 2): e27-e34.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1590/s0066-782x2011000200017
    • Vancouver

      Silva PS, Lacchini R, Gomes V de A, Tanus-Santos JE. Implicações farmacogenéticas de polimorfismos da eNOS para drogas de ação cardiovascular [Internet]. Arquivos Brasileiros de Cardiologia. 2011 ; 96( 2): e27-e34.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1590/s0066-782x2011000200017
  • Source: Molecular Human Reproduction. Unidade: FMRP

    Subjects: PRÉ-ECLÂMPSIA, ÓXIDO NÍTRICO, POLIMORFISMO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANDRIM, Valéria Cristina et al. Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia. Molecular Human Reproduction, v. 16, n. 7, p. 506-510, 2010Tradução . . Disponível em: https://doi.org/10.1093/molehr/gaq030. Acesso em: 09 jun. 2024.
    • APA

      Sandrim, V. C., Palei, A. C. T., Sertorio, J. T., Cavalli, R. de C., Duarte, G., & Tanus-Santos, J. E. (2010). Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia. Molecular Human Reproduction, 16( 7), 506-510. doi:10.1093/molehr/gaq030
    • NLM

      Sandrim VC, Palei ACT, Sertorio JT, Cavalli R de C, Duarte G, Tanus-Santos JE. Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia [Internet]. Molecular Human Reproduction. 2010 ; 16( 7): 506-510.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1093/molehr/gaq030
    • Vancouver

      Sandrim VC, Palei ACT, Sertorio JT, Cavalli R de C, Duarte G, Tanus-Santos JE. Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia [Internet]. Molecular Human Reproduction. 2010 ; 16( 7): 506-510.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1093/molehr/gaq030
  • Source: Journal of Periodontology. Unidades: FORP, FMRP, FCFRP

    Subjects: CITOQUÍMICA, INFLAMAÇÃO, PERIODONTITE

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARCACCINI, Andrea M. et al. Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. Journal of Periodontology, v. 80, n. 4, p. 594-602, 2009Tradução . . Acesso em: 09 jun. 2024.
    • APA

      Marcaccini, A. M., Meschiari, C. A., Sorgi, C. A., Saraiva, M. da C. P., Souza, A. M. de, Faccioli, L. H., et al. (2009). Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. Journal of Periodontology, 80( 4), 594-602.
    • NLM

      Marcaccini AM, Meschiari CA, Sorgi CA, Saraiva M da CP, Souza AM de, Faccioli LH, Tanus-Santos JE, Novaes Júnior AB, Gerlach RF. Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. Journal of Periodontology. 2009 ; 80( 4): 594-602.[citado 2024 jun. 09 ]
    • Vancouver

      Marcaccini AM, Meschiari CA, Sorgi CA, Saraiva M da CP, Souza AM de, Faccioli LH, Tanus-Santos JE, Novaes Júnior AB, Gerlach RF. Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. Journal of Periodontology. 2009 ; 80( 4): 594-602.[citado 2024 jun. 09 ]
  • Source: Science of the Total Environment. Unidades: FORP, FMRP, FCFRP

    Subjects: DENTE DECÍDUO, SALIVA, CRIANÇAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALMEIDA, Glauce Regina Costa de et al. Lead in saliva from lead-exposed and unexposed children. Science of the Total Environment, v. 407, n. 5, p. 1547-1550, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.scitotenv.2008.10.058. Acesso em: 09 jun. 2024.
    • APA

      Almeida, G. R. C. de, Freitas, C. U., Barbosa Júnior, F., Tanus-Santos, J. E., & Gerlach, R. F. (2009). Lead in saliva from lead-exposed and unexposed children. Science of the Total Environment, 407( 5), 1547-1550. doi:10.1016/j.scitotenv.2008.10.058
    • NLM

      Almeida GRC de, Freitas CU, Barbosa Júnior F, Tanus-Santos JE, Gerlach RF. Lead in saliva from lead-exposed and unexposed children [Internet]. Science of the Total Environment. 2009 ; 407( 5): 1547-1550.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.scitotenv.2008.10.058
    • Vancouver

      Almeida GRC de, Freitas CU, Barbosa Júnior F, Tanus-Santos JE, Gerlach RF. Lead in saliva from lead-exposed and unexposed children [Internet]. Science of the Total Environment. 2009 ; 407( 5): 1547-1550.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.scitotenv.2008.10.058
  • Source: Archives of Toxicology. Unidades: FORP, FCFRP, FMRP

    Subjects: HIPERTENSÃO, CHUMBO, DOENÇAS CARDIOVASCULARES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RIZZI, Elen et al. Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension. Archives of Toxicology, v. 83, n. 5, p. 439-449, 2009Tradução . . Disponível em: https://doi.org/10.1007/s00204-008-0363-1. Acesso em: 09 jun. 2024.
    • APA

      Rizzi, E., Castro, M. M., Fernandes, K., Barbosa Júnior, F., Arisi, G. M., Garcia-Cairasco, N., et al. (2009). Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension. Archives of Toxicology, 83( 5), 439-449. doi:10.1007/s00204-008-0363-1
    • NLM

      Rizzi E, Castro MM, Fernandes K, Barbosa Júnior F, Arisi GM, Garcia-Cairasco N, Bendhack LM, Tanus-Santos JE, Gerlach RF. Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension [Internet]. Archives of Toxicology. 2009 ; 83( 5): 439-449.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1007/s00204-008-0363-1
    • Vancouver

      Rizzi E, Castro MM, Fernandes K, Barbosa Júnior F, Arisi GM, Garcia-Cairasco N, Bendhack LM, Tanus-Santos JE, Gerlach RF. Evidence of early involvement of matrix metalloproteinase-2 in lead-induced hypertension [Internet]. Archives of Toxicology. 2009 ; 83( 5): 439-449.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1007/s00204-008-0363-1
  • Source: Hypertension Research. Unidade: FMRP

    Subjects: FARMACOGENÉTICA, HIPERTENSÃO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LACCHINI, Riccardo et al. T allele of -344C/T polymorphism in aldosterone synthase gene is not associated with resistant hypertension. Hypertension Research, v. 32, n. 2, p. 159-162, 2009Tradução . . Disponível em: https://doi.org/10.1038/hr.2008.36. Acesso em: 09 jun. 2024.
    • APA

      Lacchini, R., Sabha, M., Coeli, F. B., Favero, F., Toledo, T. de C. I., Yugar-Toledo, J. C., et al. (2009). T allele of -344C/T polymorphism in aldosterone synthase gene is not associated with resistant hypertension. Hypertension Research, 32( 2), 159-162. doi:10.1038/hr.2008.36
    • NLM

      Lacchini R, Sabha M, Coeli FB, Favero F, Toledo T de CI, Yugar-Toledo JC, Sandrim VC, Santos JET dos, Mello MP de, Moreno Junior H. T allele of -344C/T polymorphism in aldosterone synthase gene is not associated with resistant hypertension [Internet]. Hypertension Research. 2009 ; 32( 2): 159-162.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1038/hr.2008.36
    • Vancouver

      Lacchini R, Sabha M, Coeli FB, Favero F, Toledo T de CI, Yugar-Toledo JC, Sandrim VC, Santos JET dos, Mello MP de, Moreno Junior H. T allele of -344C/T polymorphism in aldosterone synthase gene is not associated with resistant hypertension [Internet]. Hypertension Research. 2009 ; 32( 2): 159-162.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1038/hr.2008.36
  • Source: Basic and Clinical Pharmacology and Toxicology. Unidade: FMRP

    Subjects: SISTEMA CARDIOVASCULAR, ÓXIDO NÍTRICO, METABÓLITOS

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MONTENEGRO, Marcelo Freitas et al. Assessment of vascular effects of tamoxifen and its metabolites on the rat perfused hindquarter vascular bed. Basic and Clinical Pharmacology and Toxicology, v. 104, n. 5, p. 400-407, 2009Tradução . . Acesso em: 09 jun. 2024.
    • APA

      Montenegro, M. F., Pessa, L. R., Gomes, V. A., Desta, Z., Flockhart, D. A., & Santos, J. E. T. dos. (2009). Assessment of vascular effects of tamoxifen and its metabolites on the rat perfused hindquarter vascular bed. Basic and Clinical Pharmacology and Toxicology, 104( 5), 400-407.
    • NLM

      Montenegro MF, Pessa LR, Gomes VA, Desta Z, Flockhart DA, Santos JET dos. Assessment of vascular effects of tamoxifen and its metabolites on the rat perfused hindquarter vascular bed. Basic and Clinical Pharmacology and Toxicology. 2009 ; 104( 5): 400-407.[citado 2024 jun. 09 ]
    • Vancouver

      Montenegro MF, Pessa LR, Gomes VA, Desta Z, Flockhart DA, Santos JET dos. Assessment of vascular effects of tamoxifen and its metabolites on the rat perfused hindquarter vascular bed. Basic and Clinical Pharmacology and Toxicology. 2009 ; 104( 5): 400-407.[citado 2024 jun. 09 ]
  • Source: Basic & Clinical Pharmacology & Toxicology. Unidade: FMRP

    Subjects: EMBOLIA PULMONAR, FÁRMACOS, PRESSÃO SANGUÍNEA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DIAS-JÚNIOR, Carlos A. et al. Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism. Basic & Clinical Pharmacology & Toxicology, v. 103, n. 4, p. 374-379, 2008Tradução . . Acesso em: 09 jun. 2024.
    • APA

      Dias-Júnior, C. A., Montenegro, M. F., Florencio, B. C., & Tanus-Santos, J. E. (2008). Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism. Basic & Clinical Pharmacology & Toxicology, 103( 4), 374-379.
    • NLM

      Dias-Júnior CA, Montenegro MF, Florencio BC, Tanus-Santos JE. Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism. Basic & Clinical Pharmacology & Toxicology. 2008 ; 103( 4): 374-379.[citado 2024 jun. 09 ]
    • Vancouver

      Dias-Júnior CA, Montenegro MF, Florencio BC, Tanus-Santos JE. Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism. Basic & Clinical Pharmacology & Toxicology. 2008 ; 103( 4): 374-379.[citado 2024 jun. 09 ]
  • Source: European Journal of Pharmacology. Unidades: FCFRP, FORP, FMRP

    Subjects: HIPERTENSÃO, DOENÇAS VASCULARES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTINEZ, Marcio L. L. et al. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European Journal of Pharmacology, v. 591, n. 1-3, p. 224-230, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.06.096. Acesso em: 09 jun. 2024.
    • APA

      Martinez, M. L. L., Castro, M. M., Rizzi, E., Fernandes, K., Demacq, C., Bendhack, L. M., et al. (2008). Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. European Journal of Pharmacology, 591( 1-3), 224-230. doi:10.1016/j.ejphar.2008.06.096
    • NLM

      Martinez MLL, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats [Internet]. European Journal of Pharmacology. 2008 ; 591( 1-3): 224-230.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2008.06.096
    • Vancouver

      Martinez MLL, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats [Internet]. European Journal of Pharmacology. 2008 ; 591( 1-3): 224-230.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2008.06.096
  • Source: Hypertension. Unidade: FMRP

    Subjects: SAÚDE DA MULHER, ÓXIDO NÍTRICO, PRÉ-ECLÂMPSIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANDRIM, Valéria C. et al. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble Fms-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertension, v. 52, n. 2, p. 402-407, 2008Tradução . . Acesso em: 09 jun. 2024.
    • APA

      Sandrim, V. C., Palei, A. C. T., Metzger, I. F., Gomes, V. A., Cavalli, R. C., & Tanus-Santos, J. E. (2008). Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble Fms-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertension, 52( 2), 402-407.
    • NLM

      Sandrim VC, Palei ACT, Metzger IF, Gomes VA, Cavalli RC, Tanus-Santos JE. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble Fms-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertension. 2008 ; 52( 2): 402-407.[citado 2024 jun. 09 ]
    • Vancouver

      Sandrim VC, Palei ACT, Metzger IF, Gomes VA, Cavalli RC, Tanus-Santos JE. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble Fms-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertension. 2008 ; 52( 2): 402-407.[citado 2024 jun. 09 ]
  • Source: Clinical Chemistry and Laboratory Medicine. Unidades: FORP, FMRP

    Subjects: POLIMORFISMO, METALOPROTEINASES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DEMACQ, Caroline et al. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects. Clinical Chemistry and Laboratory Medicine, v. 46, n. 1, p. 57-63, 2008Tradução . . Disponível em: https://doi.org/10.1515/cclm.2008.014. Acesso em: 09 jun. 2024.
    • APA

      Demacq, C., Vasconcellos, V. B., Marcaccini, A. M., Gerlach, R. F., Silva Júnior, W. A. da, & Tanus-Santos, J. E. (2008). Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects. Clinical Chemistry and Laboratory Medicine, 46( 1), 57-63. doi:10.1515/cclm.2008.014
    • NLM

      Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Silva Júnior WA da, Tanus-Santos JE. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects [Internet]. Clinical Chemistry and Laboratory Medicine. 2008 ; 46( 1): 57-63.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1515/cclm.2008.014
    • Vancouver

      Demacq C, Vasconcellos VB, Marcaccini AM, Gerlach RF, Silva Júnior WA da, Tanus-Santos JE. Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects [Internet]. Clinical Chemistry and Laboratory Medicine. 2008 ; 46( 1): 57-63.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1515/cclm.2008.014
  • Source: Pharmacogenomics. Unidade: FMRP

    Subjects: POLIMORFISMO, HIPERTENSÃO NA GRAVIDEZ, PRÉ-ECLÂMPSIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANDRIM, Valéria C. et al. eNOS haptolotypes associated with gestational hypertension on preeclampsia. Pharmacogenomics, v. 9, n. 10, p. 1467-1473, 2008Tradução . . Disponível em: https://doi.org/10.2217/14622416.9.10.1467. Acesso em: 09 jun. 2024.
    • APA

      Sandrim, V. C., Palei, A. C. T., Cavalli, R. C., Araújo, F. M., Ramos, E. S., Duarte, G., & Tanus-Santos, J. E. (2008). eNOS haptolotypes associated with gestational hypertension on preeclampsia. Pharmacogenomics, 9( 10), 1467-1473. doi:10.2217/14622416.9.10.1467
    • NLM

      Sandrim VC, Palei ACT, Cavalli RC, Araújo FM, Ramos ES, Duarte G, Tanus-Santos JE. eNOS haptolotypes associated with gestational hypertension on preeclampsia [Internet]. Pharmacogenomics. 2008 ; 9( 10): 1467-1473.[citado 2024 jun. 09 ] Available from: https://doi.org/10.2217/14622416.9.10.1467
    • Vancouver

      Sandrim VC, Palei ACT, Cavalli RC, Araújo FM, Ramos ES, Duarte G, Tanus-Santos JE. eNOS haptolotypes associated with gestational hypertension on preeclampsia [Internet]. Pharmacogenomics. 2008 ; 9( 10): 1467-1473.[citado 2024 jun. 09 ] Available from: https://doi.org/10.2217/14622416.9.10.1467
  • Source: Clinical Biochemistry. Unidade: FMRP

    Subjects: HIPERTENSÃO NA GRAVIDEZ, PRÉ-ECLÂMPSIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PALEI, Ana C. T. et al. Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. Clinical Biochemistry, v. 41, n. 10-11, p. 875-880, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.clinbiochem.2008.04.015. Acesso em: 09 jun. 2024.
    • APA

      Palei, A. C. T., Sandrim, V. C., Cavalli, R. C., & Tanus-Santos, J. E. (2008). Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. Clinical Biochemistry, 41( 10-11), 875-880. doi:10.1016/j.clinbiochem.2008.04.015
    • NLM

      Palei ACT, Sandrim VC, Cavalli RC, Tanus-Santos JE. Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension [Internet]. Clinical Biochemistry. 2008 ; 41( 10-11): 875-880.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.clinbiochem.2008.04.015
    • Vancouver

      Palei ACT, Sandrim VC, Cavalli RC, Tanus-Santos JE. Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension [Internet]. Clinical Biochemistry. 2008 ; 41( 10-11): 875-880.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.clinbiochem.2008.04.015
  • Source: European Journal of Pharmacology. Unidades: FMRP, FCFRP, FORP

    Subjects: DIABETES MELLITUS, METALOPROTEINASES, DOENÇAS CARDIOVASCULARES, ESTRESSE OXIDATIVO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTINEZ, Marcio L. L. et al. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, v. 599, n. 1-3, p. 110-116, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.10.007. Acesso em: 09 jun. 2024.
    • APA

      Martinez, M. L. L., Rizzi, E., Castro, M. M., Fernandes, K., Bendhack, L. M., Gerlach, R. F., & Tanus-Santos, J. E. (2008). Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, 599( 1-3), 110-116. doi:10.1016/j.ejphar.2008.10.007
    • NLM

      Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007
    • Vancouver

      Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007
  • Source: Acta Physiologica. Unidade: FMRP

    Subjects: TROMBOEMBOLISMO, INIBIDORES DE ENZIMAS, ÓXIDO NÍTRICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DIAS-JÚNIOR, C. A. C. e SERTORIO, J. T. C. e TANUS-SANTOS, José Eduardo. Aminoguanidine produces beneficial haemodynamic effects in a canine model of acute pulmonary thromboembolism. Acta Physiologica, v. 191, p. 189-196, 2007Tradução . . Disponível em: https://doi.org/10.1111/j.1748-1716.2007.01746.x. Acesso em: 09 jun. 2024.
    • APA

      Dias-Júnior, C. A. C., Sertorio, J. T. C., & Tanus-Santos, J. E. (2007). Aminoguanidine produces beneficial haemodynamic effects in a canine model of acute pulmonary thromboembolism. Acta Physiologica, 191, 189-196. doi:10.1111/j.1748-1716.2007.01746.x
    • NLM

      Dias-Júnior CAC, Sertorio JTC, Tanus-Santos JE. Aminoguanidine produces beneficial haemodynamic effects in a canine model of acute pulmonary thromboembolism [Internet]. Acta Physiologica. 2007 ; 191 189-196.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1111/j.1748-1716.2007.01746.x
    • Vancouver

      Dias-Júnior CAC, Sertorio JTC, Tanus-Santos JE. Aminoguanidine produces beneficial haemodynamic effects in a canine model of acute pulmonary thromboembolism [Internet]. Acta Physiologica. 2007 ; 191 189-196.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1111/j.1748-1716.2007.01746.x
  • Source: Clinical Biochemistry. Unidades: FORP, FMRP

    Assunto: METALOPROTEINASES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GERLACH, Raquel Fernanda et al. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma. Clinical Biochemistry, v. 40, p. 119-123, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.clinbiochem.2006.10.007. Acesso em: 09 jun. 2024.
    • APA

      Gerlach, R. F., Demacq, C., Jung, K., & Tanus-Santos, J. E. (2007). Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma. Clinical Biochemistry, 40, 119-123. doi:10.1016/j.clinbiochem.2006.10.007
    • NLM

      Gerlach RF, Demacq C, Jung K, Tanus-Santos JE. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma [Internet]. Clinical Biochemistry. 2007 ; 40 119-123.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.clinbiochem.2006.10.007
    • Vancouver

      Gerlach RF, Demacq C, Jung K, Tanus-Santos JE. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma [Internet]. Clinical Biochemistry. 2007 ; 40 119-123.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.clinbiochem.2006.10.007
  • Source: Nitric Oxide. Unidade: FMRP

    Subjects: POLIMORFISMO, HIPERTENSÃO, ÓXIDO NÍTRICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SANDRIM, Valéria C. et al. Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide, v. 16, p. 348-355, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2006.12.007. Acesso em: 09 jun. 2024.
    • APA

      Sandrim, V. C., Syllos, R. W. C. de, Lisboa, H. R. K., Tres, G. S., & Tanus-Santos, J. E. (2007). Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide, 16, 348-355. doi:10.1016/j.niox.2006.12.007
    • NLM

      Sandrim VC, Syllos RWC de, Lisboa HRK, Tres GS, Tanus-Santos JE. Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients [Internet]. Nitric Oxide. 2007 ; 16 348-355.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.niox.2006.12.007
    • Vancouver

      Sandrim VC, Syllos RWC de, Lisboa HRK, Tres GS, Tanus-Santos JE. Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients [Internet]. Nitric Oxide. 2007 ; 16 348-355.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.niox.2006.12.007
  • Source: International Journal of Cardiology. Unidades: FORP, FMRP

    Subjects: DOENÇAS CARDIOVASCULARES, FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FORTUNA, Geisa M. et al. A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism. International Journal of Cardiology, v. 114, n. 1, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2005.11.109. Acesso em: 09 jun. 2024.
    • APA

      Fortuna, G. M., Figueiredo-Lopes, L., Dias-Júnior, C. A. C., Gerlach, R. F., & Tanus-Santos, J. E. (2007). A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism. International Journal of Cardiology, 114( 1). doi:10.1016/j.ijcard.2005.11.109
    • NLM

      Fortuna GM, Figueiredo-Lopes L, Dias-Júnior CAC, Gerlach RF, Tanus-Santos JE. A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism [Internet]. International Journal of Cardiology. 2007 ; 114( 1):[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.ijcard.2005.11.109
    • Vancouver

      Fortuna GM, Figueiredo-Lopes L, Dias-Júnior CAC, Gerlach RF, Tanus-Santos JE. A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism [Internet]. International Journal of Cardiology. 2007 ; 114( 1):[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.ijcard.2005.11.109
  • Source: Clinica Chimica Acta. Unidades: FORP, FMRP, FCFRP

    Subjects: VITAMINA D, GENÓTIPOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      REZENDE, Vania B. et al. An interethnic comparison of the distribution of vitamin D receptor genotypes and haplotypes. Clinica Chimica Acta, v. 384, n. 1-2, p. 155-159, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2007.05.010. Acesso em: 09 jun. 2024.
    • APA

      Rezende, V. B., Barbosa Júnior, F., Montenegro, M. F., Sandrim, V. C., Gerlach, R. F., & Tanus-Santos, J. E. (2007). An interethnic comparison of the distribution of vitamin D receptor genotypes and haplotypes. Clinica Chimica Acta, 384( 1-2), 155-159. doi:10.1016/j.cca.2007.05.010
    • NLM

      Rezende VB, Barbosa Júnior F, Montenegro MF, Sandrim VC, Gerlach RF, Tanus-Santos JE. An interethnic comparison of the distribution of vitamin D receptor genotypes and haplotypes [Internet]. Clinica Chimica Acta. 2007 ; 384( 1-2): 155-159.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.cca.2007.05.010
    • Vancouver

      Rezende VB, Barbosa Júnior F, Montenegro MF, Sandrim VC, Gerlach RF, Tanus-Santos JE. An interethnic comparison of the distribution of vitamin D receptor genotypes and haplotypes [Internet]. Clinica Chimica Acta. 2007 ; 384( 1-2): 155-159.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.cca.2007.05.010
  • Source: Free Radical Biology and Medicine. Unidade: FMRP

    Subjects: GENÓTIPOS, ÓXIDO NÍTRICO, POLIMORFISMO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      METZGER, Ingrid F. e SERTÓRIO, Jonas T. C. e TANUS-SANTOS, José Eduardo. Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radical Biology and Medicine, v. 43, p. 987-992, 2007Tradução . . Disponível em: https://doi.org/10.1016/j.freeradbiomed.2007.06.012. Acesso em: 09 jun. 2024.
    • APA

      Metzger, I. F., Sertório, J. T. C., & Tanus-Santos, J. E. (2007). Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radical Biology and Medicine, 43, 987-992. doi:10.1016/j.freeradbiomed.2007.06.012
    • NLM

      Metzger IF, Sertório JTC, Tanus-Santos JE. Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes [Internet]. Free Radical Biology and Medicine. 2007 ; 43 987-992.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2007.06.012
    • Vancouver

      Metzger IF, Sertório JTC, Tanus-Santos JE. Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes [Internet]. Free Radical Biology and Medicine. 2007 ; 43 987-992.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1016/j.freeradbiomed.2007.06.012

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024